For: | Wei S, Xu S, Pan YH. Efficacy of arbidol in COVID-19 patients: A retrospective study. World J Clin Cases 2021; 9(25): 7350-7357 [PMID: 34616801 DOI: 10.12998/wjcc.v9.i25.7350] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i25/7350.htm |
Number | Citing Articles |
1 |
Chuyuan Zhang, Xinjie Meng, Hanjun Zhao. Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2. International Journal of Molecular Sciences 2022; 23(13): 7365 doi: 10.3390/ijms23137365
|
2 |
Jaikee Kumar Singh, Saumya Dubey, Gaurava Srivastava, Mohammad Imran Siddiqi, Sandeep Kumar Srivastava. Neohesperidin and spike RBD interaction in omicron and its sub-variants: In silico, structural and simulation studies. Computers in Biology and Medicine 2023; 152: 106392 doi: 10.1016/j.compbiomed.2022.106392
|
3 |
Zirui Lü, Xiandong Dai, Jianjie Xu, Zhenming Liu, Yongbiao Guo, Zhenhua Gao, Fanhua Meng. Medicinal chemistry strategies toward broad-spectrum antiviral agents to prevent next pandemics. European Journal of Medicinal Chemistry 2024; 271: 116442 doi: 10.1016/j.ejmech.2024.116442
|
4 |
Nehmedo G. Fawazy, Siva S. Panda, Ahmed Mostafa, Benson M. Kariuki, Mohamed S. Bekheit, Yassmin Moatasim, Omnia Kutkat, Walid Fayad, May A. El-Manawaty, Ahmed A. F. Soliman, Riham A. El-Shiekh, Aladdin M. Srour, Reham F. Barghash, Adel S. Girgis. Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-17883-9
|
5 |
Mohamed S. Bekheit, Siva S. Panda, Benson M. Kariuki, Sara H. Mahmoud, Ahmed Mostafa, Adel S. Girgis. Spiroindole-containing compounds bearing phosphonate group of potential Mpro-SARS-CoV-2 inhibitory properties. European Journal of Medicinal Chemistry 2023; 258: 115563 doi: 10.1016/j.ejmech.2023.115563
|
6 |
Yu-Xuan Huang, Na-Fen Li, Chen-Yao Li, Fang-Ping Zheng, Xiang-Yang Yao, Bao-Hua Lin, Xian-Zhong Huang, Neng-Jiang Zhao, Jia-Yong Yang, Qiu-Min Chen, Man-Man Zhang, Li-Tao Yi, Xue-Qin Chen. Clinical features and effectiveness of Chinese medicine in patients with COVID-19 from overseas: A retrospective study in Xiamen, China. Frontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.1038017
|
7 |
Prabhat Ranjan, Tanmoy Chakraborty. Computational insight of repurpose drug for treatment of COVID-19: a CDFT approach. Theoretical Chemistry Accounts 2024; 143(1) doi: 10.1007/s00214-023-03082-w
|
8 |
Ali Azargoonjahromi. Role of the SARS-CoV-2 Virus in Brain Cells. Viral Immunology 2024; 37(2): 61 doi: 10.1089/vim.2023.0116
|
9 |
Armina Alagheband Bahrami, Ali Azargoonjahromi, Samin Sadraei, Aryan Aarabi, Zahra Payandeh, Masoumeh Rajabibazl. An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19). Cellular & Molecular Biology Letters 2022; 27(1) doi: 10.1186/s11658-022-00339-3
|